GABRIEL PETTY: Open Payments
NPI 1447485214 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,827 in 18 payments from 13 companies in 2025. Trend: 2023 $815 · 2024 $1,533 · 2025 $1,827
Food & beverage: $1,813Travel & lodging: $14
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $358 |
| Abbott Laboratories | 2 | $256 |
| SCPHARMACEUTICALS INC. | 2 | $150 |
| Bolton Medical Inc | 2 | $135 |
| SANOFI US SERVICES INC. | 1 | $132 |
| Phathom Pharmaceuticals, Inc. | 1 | $132 |
| Alkermes, Inc. | 1 | $125 |
| GENZYME CORPORATION | 1 | $123 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $118 |
| Lilly USA, LLC | 1 | $116 |
Products named: PROCLAIM, FUROSCIX, AYVAKIT, VOQUEZNA, VIVITROL, Wegovy, KEVZARA, XIFAXAN.
Industry payments across TX — which companies pay providers there.
